Virtual assistant designed to support hematologists, internists, primary care physicians, oncologists, onco-hematology nursing staff, and hospital pharmacy professionals in the diagnosis, treatment, and follow-up of multiple myeloma, based on the most recent scientific evidence (IMWG, ESMO, NCCN) and the clinical guidelines in effect as of August 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.